ETF Managers Group LLC Purchases Shares of 4,569,184 22nd Century Group Inc (XXII)

ETF Managers Group LLC purchased a new stake in 22nd Century Group Inc (NYSEAMERICAN:XXII) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 4,569,184 shares of the biotechnology company’s stock, valued at approximately $12,108,000.

Several other hedge funds have also added to or reduced their stakes in the stock. SG Americas Securities LLC grew its stake in shares of 22nd Century Group by 56.5% in the fourth quarter. SG Americas Securities LLC now owns 26,784 shares of the biotechnology company’s stock valued at $67,000 after acquiring an additional 9,672 shares in the last quarter. Teachers Advisors LLC grew its stake in shares of 22nd Century Group by 14.2% in the third quarter. Teachers Advisors LLC now owns 254,210 shares of the biotechnology company’s stock valued at $714,000 after acquiring an additional 31,537 shares in the last quarter. Wells Fargo & Company MN grew its stake in shares of 22nd Century Group by 19.0% in the third quarter. Wells Fargo & Company MN now owns 260,723 shares of the biotechnology company’s stock valued at $733,000 after acquiring an additional 41,664 shares in the last quarter. Voya Investment Management LLC acquired a new position in shares of 22nd Century Group in the second quarter valued at about $106,000. Finally, Rhumbline Advisers grew its stake in shares of 22nd Century Group by 50.8% in the fourth quarter. Rhumbline Advisers now owns 145,030 shares of the biotechnology company’s stock valued at $361,000 after acquiring an additional 48,874 shares in the last quarter.

Shares of 22nd Century Group stock opened at $2.30 on Wednesday. 22nd Century Group Inc has a 12-month low of $1.92 and a 12-month high of $3.29.

22nd Century Group (NYSEAMERICAN:XXII) last announced its quarterly earnings data on Wednesday, November 7th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $6.26 million for the quarter.

Separately, TheStreet upgraded shares of 22nd Century Group from a “d” rating to a “c-” rating in a research note on Monday, November 26th.

WARNING: This piece of content was originally published by Enterprise Leader and is the sole property of of Enterprise Leader. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://theenterpriseleader.com/2019/02/06/etf-managers-group-llc-purchases-shares-of-4569184-22nd-century-group-inc-xxii.html.

About 22nd Century Group

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.

Featured Story: What is an SEC Filing?

Want to see what other hedge funds are holding XXII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 22nd Century Group Inc (NYSEAMERICAN:XXII).

Institutional Ownership by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply